KIT and gastrointestinal stromal tumor: These results suggested that TAS-116 might inhibit the KIT-dependent proliferation of GISTs by the depletion of pKIT and that we may be able to predict the therapeutic effect of TAS-116 in IM-resistant GIST through the measurement of KIT activities in a clinical setting.